"pathway" "pval" "padj" "ES" "NES" "nMoreExtreme" "size" "leadingEdge"
"1" "CERVERA_SDHB_TARGETS_2" 0.0010366991499067 0.0827630248523229 0.98974254351567 1.4736824814842 4 2 "C2"
"2" "WANG_MLL_TARGETS" 0.0010366991499067 0.0827630248523229 0.98974254351567 1.4736824814842 4 2 "C2"
"3" "ABE_VEGFA_TARGETS_30MIN" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"4" "BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"5" "CHEBOTAEV_GR_TARGETS_DN" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"6" "FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"7" "GRUETZMANN_PANCREATIC_CANCER_UP" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"8" "JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"9" "MARKEY_RB1_ACUTE_LOF_DN" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"10" "ONKEN_UVEAL_MELANOMA_UP" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"11" "RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"12" "ROSS_AML_WITH_MLL_FUSIONS" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"13" "VERHAAK_AML_WITH_NPM1_MUTATED_UP" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"14" "ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"15" "ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"16" "ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"17" "KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"18" "KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"19" "WP_OXIDATIVE_DAMAGE_RESPONSE" 0.00364004044489383 0.0827630248523229 0.998558962452966 1.32628473599516 17 1 "C2"
"20" "DELYS_THYROID_CANCER_UP" 0.0165871863985072 0.298569355173129 0.958395875998553 1.42700869235032 79 2 "C2"
"21" "FEVR_CTNNB1_TARGETS_UP" 0.0165871863985072 0.298569355173129 0.958395875998553 1.42700869235032 79 2 "C2"
"22" "GAURNIER_PSMD4_TARGETS" 0.0165871863985072 0.298569355173129 0.958395875998553 1.42700869235032 79 2 "C2"
"23" "REACTOME_ACTIVATION_OF_C3_AND_C5" 0.0165871863985072 0.298569355173129 0.958395875998553 1.42700869235032 79 2 "C2"
"24" "REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT" 0.0165871863985072 0.298569355173129 0.958395875998553 1.42700869235032 79 2 "C2"
"25" "BROWN_MYELOID_CELL_DEVELOPMENT_UP" 0.0257312513745327 0.444636023751924 0.89658844392355 1.47833887117308 116 3 "C2"
"26" "LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_DN" 0.0456793030374382 0.609819146072127 0.82516529183864 1.48423555563963 193 4 "C2"
"27" "PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP" 0.0859907631405322 0.609819146072127 0.831287996451653 1.37066830006885 390 3 "C2"
"28" "CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN" 0.134212385213092 0.609819146072127 0.748497264163852 1.34633177589857 569 4 "C2"
"29" "BIOCARTA_CLASSIC_PATHWAY" 0.177066164351307 0.609819146072127 0.72116493784826 1.29716876463624 751 4 "C2"
"30" "BIOCARTA_COMP_PATHWAY" 0.177066164351307 0.609819146072127 0.72116493784826 1.29716876463624 751 4 "C2"
"31" "BIOCARTA_LECTIN_PATHWAY" 0.177066164351307 0.609819146072127 0.72116493784826 1.29716876463624 751 4 "C2"
"32" "KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS" 0.177066164351307 0.609819146072127 0.72116493784826 1.29716876463624 751 4 "C2"
"33" "WP_ALLOGRAFT_REJECTION" 0.177066164351307 0.609819146072127 0.72116493784826 1.29716876463624 751 4 "C2"
"34" "WP_COMPLEMENT_ACTIVATION" 0.177066164351307 0.609819146072127 0.72116493784826 1.29716876463624 751 4 "C2"
"35" "WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY" 0.177066164351307 0.609819146072127 0.72116493784826 1.29716876463624 751 4 "C2"
"36" "CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"37" "ENK_UV_RESPONSE_EPIDERMIS_UP" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"38" "HAMAI_APOPTOSIS_VIA_TRAIL_DN" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"39" "MARSON_BOUND_BY_FOXP3_UNSTIMULATED" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"40" "NUYTTEN_EZH2_TARGETS_DN" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"41" "PROVENZANI_METASTASIS_DN" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"42" "SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"43" "SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"44" "SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"45" "SU_LIVER" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"46" "VECCHI_GASTRIC_CANCER_EARLY_UP" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"47" "WANG_CLIM2_TARGETS_DN" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"48" "WANG_LMO4_TARGETS_DN" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"49" "ZAMORA_NOS2_TARGETS_DN" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"50" "WP_5Q35_COPY_NUMBER_VARIATION" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"51" "WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"52" "WP_KININKALLIKREIN_PATHWAY" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"53" "WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19" 0.23432865335179 0.609819146072127 -0.87871267312465 -1.17500279804635 1184 1 "F12"
"54" "CERVERA_SDHB_TARGETS_1_DN" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"55" "HEBERT_MATRISOME_TNBC_LIVER_METASTASIS" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"56" "LEE_AGING_CEREBELLUM_UP" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"57" "NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"58" "NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"59" "NABA_MATRISOME_POORLY_METASTATIC_MELANOMA" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"60" "NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"61" "PILON_KLF1_TARGETS_UP" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"62" "ROVERSI_GLIOMA_COPY_NUMBER_UP" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"63" "YAGI_AML_WITH_T_9_11_TRANSLOCATION" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"64" "YOSHIMURA_MAPK8_TARGETS_DN" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"65" "BIOCARTA_BIOPEPTIDES_PATHWAY" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"66" "BIOCARTA_FIBRINOLYSIS_PATHWAY" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"67" "BIOCARTA_NFAT_PATHWAY" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"68" "BIOCARTA_PAR1_PATHWAY" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"69" "BIOCARTA_SPPA_PATHWAY" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"70" "KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"71" "KEGG_REGULATION_OF_ACTIN_CYTOSKELETON" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"72" "KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"73" "PID_ANGIOPOIETIN_RECEPTOR_PATHWAY" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"74" "PID_HNF3B_PATHWAY" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"75" "PID_SYNDECAN_4_PATHWAY" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"76" "PID_THROMBIN_PAR1_PATHWAY" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"77" "PID_THROMBIN_PAR4_PATHWAY" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"78" "REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"79" "REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"80" "REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"81" "REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"82" "WP_CANCER_PATHWAYS" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"83" "WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"84" "WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"85" "WP_REGULATION_OF_ACTIN_CYTOSKELETON" 0.218311251730275 0.609819146072127 -0.888960051236891 -1.18870545458334 1103 1 "F2"
"86" "ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"87" "AMIT_EGF_RESPONSE_120_HELA" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"88" "BAELDE_DIABETIC_NEPHROPATHY_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"89" "BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"90" "BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"91" "BROWNE_HCMV_INFECTION_2HR_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"92" "BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"93" "BURTON_ADIPOGENESIS_9" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"94" "BURTON_ADIPOGENESIS_PEAK_AT_0HR" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"95" "CHEN_HOXA5_TARGETS_9HR_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"96" "DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"97" "DACOSTA_UV_RESPONSE_VIA_ERCC3_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"98" "DANG_REGULATED_BY_MYC_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"99" "ENK_UV_RESPONSE_EPIDERMIS_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"100" "FRIDMAN_SENESCENCE_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"101" "GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"102" "GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"103" "HAN_SATB1_TARGETS_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"104" "HARRIS_HYPOXIA" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"105" "HASINA_NOL7_TARGETS_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"106" "HUANG_DASATINIB_SENSITIVITY_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"107" "IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"108" "JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"109" "KIM_HYPOXIA" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"110" "KIM_LIVER_CANCER_POOR_SURVIVAL_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"111" "KIM_WT1_TARGETS_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"112" "KOBAYASHI_EGFR_SIGNALING_6HR_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"113" "KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"114" "KUNINGER_IGF1_VS_PDGFB_TARGETS_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"115" "LANDIS_ERBB2_BREAST_TUMORS_324_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"116" "LA_MEN1_TARGETS" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"117" "LEE_LIVER_CANCER_HEPATOBLAST" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"118" "LEE_NEURAL_CREST_STEM_CELL_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"119" "LEONARD_HYPOXIA" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"120" "LINSLEY_MIR16_TARGETS" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"121" "MAINA_HYPOXIA_VHL_TARGETS_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"122" "MAINA_VHL_TARGETS_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"123" "MCBRYAN_PUBERTAL_BREAST_4_5WK_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"124" "MCBRYAN_PUBERTAL_BREAST_6_7WK_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"125" "MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"126" "MEBARKI_HCC_PROGENITOR_WNT_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"127" "MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"128" "MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"129" "MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"130" "MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"131" "MILI_PSEUDOPODIA_CHEMOTAXIS_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"132" "MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"133" "NAGASHIMA_NRG1_SIGNALING_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"134" "NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"135" "NGUYEN_NOTCH1_TARGETS_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"136" "NOUSHMEHR_GBM_SILENCED_BY_METHYLATION" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"137" "PASINI_SUZ12_TARGETS_DN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"138" "PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"139" "PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"140" "SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"141" "SESTO_RESPONSE_TO_UV_C2" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"142" "UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"143" "VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"144" "WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"145" "WANG_METHYLATED_IN_BREAST_CANCER" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"146" "WINTER_HYPOXIA_METAGENE" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"147" "WINZEN_DEGRADED_VIA_KHSRP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"148" "WONG_ADULT_TISSUE_STEM_MODULE" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"149" "YAMAZAKI_TCEB3_TARGETS_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"150" "ZHENG_GLIOBLASTOMA_PLASTICITY_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"151" "ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"152" "ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"153" "REACTOME_NGF_STIMULATED_TRANSCRIPTION" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"154" "REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"155" "REACTOME_SIGNALING_BY_NTRKS" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"156" "REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"157" "WP_MACROPHAGE_MARKERS" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"158" "WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"159" "WP_VEGFAVEGFR2_SIGNALING" 0.162744710302551 0.609819146072127 -0.916820110479545 -1.22595955204326 822 1 "F3"
"160" "MIKKELSEN_ES_LCP_WITH_H3K4ME3" 0.187451737451737 0.609819146072127 -0.86239700532048 -1.25521097625054 970 2 "F2"
"161" "MIKKELSEN_IPS_LCP_WITH_H3K4ME3" 0.187451737451737 0.609819146072127 -0.86239700532048 -1.25521097625054 970 2 "F2"
"162" "REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION" 0.187451737451737 0.609819146072127 -0.86239700532048 -1.25521097625054 970 2 "F2"
"163" "REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE" 0.166329861650863 0.609819146072127 -0.708971982820623 -1.28978452456637 1069 7 "F3, F2, F12, F11, F7, F10"
"164" "REACTOME_HEMOSTASIS" 0.166329861650863 0.609819146072127 -0.708971982820623 -1.28978452456637 1069 7 "F3, F2, F12, F11, F7, F10"
"165" "WP_BLOOD_CLOTTING_CASCADE" 0.166329861650863 0.609819146072127 -0.708971982820623 -1.28978452456637 1069 7 "F3, F2, F12, F11, F7, F10"
"166" "LEE_BMP2_TARGETS_UP" 0.117953667953668 0.609819146072127 -0.897356330518879 -1.30609395525049 610 2 "F3"
"167" "LEE_LIVER_CANCER_SURVIVAL_UP" 0.252694084011436 0.62148504010436 0.728428560571144 1.20106863217256 1148 3 "C2"
"168" "BLALOCK_ALZHEIMERS_DISEASE_UP" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"169" "BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"170" "CAIRO_HEPATOBLASTOMA_CLASSES_DN" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"171" "CHICAS_RB1_TARGETS_CONFLUENT" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"172" "CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"173" "FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"174" "FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"175" "HOELZEL_NF1_TARGETS_DN" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"176" "LOPEZ_MBD_TARGETS" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"177" "MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"178" "RODWELL_AGING_KIDNEY_UP" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"179" "SABATES_COLORECTAL_ADENOMA_DN" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"180" "SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"181" "TANG_SENESCENCE_TP53_TARGETS_UP" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"182" "TOMLINS_PROSTATE_CANCER_DN" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"183" "ZHENG_IL22_SIGNALING_DN" 0.277654196157735 0.62148504010436 0.865743335201345 1.14987918985421 1372 1 "C7"
"184" "BIOCARTA_INTRINSIC_PATHWAY" 0.276370259976817 0.62148504010436 -0.704452291879958 -1.20134142339256 1668 5 "F2, F12, F11, F10"
"185" "BIOCARTA_EXTRINSIC_PATHWAY" 0.272396092068223 0.62148504010436 -0.706078402125354 -1.20411451905754 1644 5 "F3, F2, F7, F10"
"186" "HSIAO_LIVER_SPECIFIC_GENES" 0.263485154671226 0.62148504010436 -0.662368976043568 -1.20500284292619 1694 7 "F2, F12, F11, F7, F10"
"187" "CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN" 0.259459459459459 0.62148504010436 -0.829703763010408 -1.20762626022805 1343 2 "F12, C6"
"188" "BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP" 0.255212355212355 0.62148504010436 -0.831434806052127 -1.2101457775883 1321 2 "F3"
"189" "CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN" 0.255212355212355 0.62148504010436 -0.831434806052127 -1.2101457775883 1321 2 "F3"
"190" "COLINA_TARGETS_OF_4EBP1_AND_4EBP2" 0.255212355212355 0.62148504010436 -0.831434806052127 -1.2101457775883 1321 2 "F3"
"191" "FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP" 0.255212355212355 0.62148504010436 -0.831434806052127 -1.2101457775883 1321 2 "F3"
"192" "ONDER_CDH1_TARGETS_2_DN" 0.255212355212355 0.62148504010436 -0.831434806052127 -1.2101457775883 1321 2 "F3"
"193" "YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6" 0.255212355212355 0.62148504010436 -0.831434806052127 -1.2101457775883 1321 2 "F3"
"194" "GRUETZMANN_PANCREATIC_CANCER_DN" 0.309440879926673 0.685530564760629 -0.762430939226519 -1.18266707032114 1687 3 "F12, C6, F11"
"195" "OHGUCHI_LIVER_HNF4A_TARGETS_DN" 0.309440879926673 0.685530564760629 -0.762430939226519 -1.18266707032114 1687 3 "F12, C6, F11"
"196" "WP_COMPLEMENT_SYSTEM" 0.336789016531241 0.693578914658606 0.5354489125615 1.13834972090124 1201 7 "C2"
"197" "BENPORATH_CYCLING_GENES" 0.337156416847934 0.693578914658606 -0.829637338883996 -1.1093799194747 1704 1 "C6"
"198" "BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING" 0.337156416847934 0.693578914658606 -0.829637338883996 -1.1093799194747 1704 1 "C6"
"199" "CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN" 0.337156416847934 0.693578914658606 -0.829637338883996 -1.1093799194747 1704 1 "C6"
"200" "LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP" 0.337156416847934 0.693578914658606 -0.829637338883996 -1.1093799194747 1704 1 "C6"
"201" "SHEPARD_CRASH_AND_BURN_MUTANT_UP" 0.337156416847934 0.693578914658606 -0.829637338883996 -1.1093799194747 1704 1 "C6"
"202" "SPIRA_SMOKERS_LUNG_CANCER_UP" 0.337156416847934 0.693578914658606 -0.829637338883996 -1.1093799194747 1704 1 "C6"
"203" "WHITFIELD_CELL_CYCLE_G2_M" 0.337156416847934 0.693578914658606 -0.829637338883996 -1.1093799194747 1704 1 "C6"
"204" "NABA_ECM_REGULATORS" 0.332232841007819 0.693578914658606 -0.715406790518898 -1.16441829110095 1911 4 "F2, F12, F7, F10"
"205" "NABA_MATRISOME" 0.332232841007819 0.693578914658606 -0.715406790518898 -1.16441829110095 1911 4 "F2, F12, F7, F10"
"206" "NABA_MATRISOME_ASSOCIATED" 0.332232841007819 0.693578914658606 -0.715406790518898 -1.16441829110095 1911 4 "F2, F12, F7, F10"
"207" "REACTOME_DEFECTS_OF_CONTACT_ACTIVATION_SYSTEM_CAS_AND_KALLIKREIN_KININ_SYSTEM_KKS" 0.332232841007819 0.693578914658606 -0.715406790518898 -1.16441829110095 1911 4 "F2, F12, F11, F10"
"208" "REACTOME_DISEASES_OF_HEMOSTASIS" 0.332232841007819 0.693578914658606 -0.715406790518898 -1.16441829110095 1911 4 "F2, F12, F11, F10"
"209" "REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION" 0.332232841007819 0.693578914658606 -0.715406790518898 -1.16441829110095 1911 4 "F2, F12, F11, F10"
"210" "REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS" 0.327589367552704 0.693578914658606 -0.754289781682169 -1.17003867547692 1786 3 "F2"
"211" "REACTOME_COMPLEMENT_CASCADE" 0.377491799142064 0.703254274682846 0.583370912668433 1.11521041106626 1495 5 "C2"
"212" "REACTOME_INNATE_IMMUNE_SYSTEM" 0.377491799142064 0.703254274682846 0.583370912668433 1.11521041106626 1495 5 "C2"
"213" "BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP" 0.403203480324303 0.703254274682846 -0.798094628132255 -1.0672014298218 2038 1 "C9orf72"
"214" "BURTON_ADIPOGENESIS_6" 0.403203480324303 0.703254274682846 -0.798094628132255 -1.0672014298218 2038 1 "C9orf72"
"215" "COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP" 0.403203480324303 0.703254274682846 -0.798094628132255 -1.0672014298218 2038 1 "C9orf72"
"216" "GHANDHI_BYSTANDER_IRRADIATION_UP" 0.403203480324303 0.703254274682846 -0.798094628132255 -1.0672014298218 2038 1 "C9orf72"
"217" "KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP" 0.403203480324303 0.703254274682846 -0.798094628132255 -1.0672014298218 2038 1 "C9orf72"
"218" "PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7" 0.403203480324303 0.703254274682846 -0.798094628132255 -1.0672014298218 2038 1 "C9orf72"
"219" "SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN" 0.403203480324303 0.703254274682846 -0.798094628132255 -1.0672014298218 2038 1 "C9orf72"
"220" "STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN" 0.403203480324303 0.703254274682846 -0.798094628132255 -1.0672014298218 2038 1 "C9orf72"
"221" "KEGG_MEDICUS_REFERENCE_C9ORF72_MEDIATED_AUTOPHAGY_INITIATION" 0.403203480324303 0.703254274682846 -0.798094628132255 -1.0672014298218 2038 1 "C9orf72"
"222" "WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES" 0.403203480324303 0.703254274682846 -0.798094628132255 -1.0672014298218 2038 1 "C9orf72"
"223" "WP_MESODERMAL_COMMITMENT_PATHWAY" 0.403203480324303 0.703254274682846 -0.798094628132255 -1.0672014298218 2038 1 "C9orf72"
"224" "WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION" 0.403203480324303 0.703254274682846 -0.798094628132255 -1.0672014298218 2038 1 "C9orf72"
"225" "BOCHKIS_FOXA2_TARGETS" 0.41023166023166 0.703254274682846 -0.754763811048839 -1.0985518435945 2124 2 "C6, F7"
"226" "OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP" 0.41023166023166 0.703254274682846 -0.754763811048839 -1.0985518435945 2124 2 "F3, F7"
"227" "VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN" 0.41023166023166 0.703254274682846 -0.754763811048839 -1.0985518435945 2124 2 "F2, F7"
"228" "YAGI_AML_WITH_INV_16_TRANSLOCATION" 0.41023166023166 0.703254274682846 -0.754763811048839 -1.0985518435945 2124 2 "F2, F7"
"229" "WP_FOLATE_METABOLISM" 0.41023166023166 0.703254274682846 -0.754763811048839 -1.0985518435945 2124 2 "F2, F7"
"230" "WP_SELENIUM_MICRONUTRIENT_NETWORK" 0.41023166023166 0.703254274682846 -0.754763811048839 -1.0985518435945 2124 2 "F2, F7"
"231" "WP_VITAMIN_B12_METABOLISM" 0.41023166023166 0.703254274682846 -0.754763811048839 -1.0985518435945 2124 2 "F2, F7"
"232" "ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY" 0.393243243243243 0.703254274682846 -0.762369895916733 -1.10962243075282 2036 2 "F2, F11"
"233" "BIOCARTA_PLATELETAPP_PATHWAY" 0.393243243243243 0.703254274682846 -0.762369895916733 -1.10962243075282 2036 2 "F2, F11"
"234" "CAIRO_HEPATOBLASTOMA_DN" 0.393243243243243 0.703254274682846 -0.762369895916733 -1.10962243075282 2036 2 "C6, F11"
"235" "SERVITJA_LIVER_HNF1A_TARGETS_DN" 0.393243243243243 0.703254274682846 -0.762369895916733 -1.10962243075282 2036 2 "C6, F11"
"236" "YAMASHITA_LIVER_CANCER_STEM_CELL_DN" 0.393243243243243 0.703254274682846 -0.762369895916733 -1.10962243075282 2036 2 "C6, F11"
"237" "CHEN_METABOLIC_SYNDROM_NETWORK" 0.407516040329973 0.703254274682846 -0.715349507566659 -1.10963532936873 2222 3 "F11, F7, F10"
"238" "SWEET_LUNG_CANCER_KRAS_UP" 0.407516040329973 0.703254274682846 -0.715349507566659 -1.10963532936873 2222 3 "F3, F7, F10"
"239" "BIOCARTA_AMI_PATHWAY" 0.407516040329973 0.703254274682846 -0.715349507566659 -1.10963532936873 2222 3 "F2, F7, F10"
"240" "REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION" 0.407516040329973 0.703254274682846 -0.715349507566659 -1.10963532936873 2222 3 "F3, F7, F10"
"241" "REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION" 0.407516040329973 0.703254274682846 -0.715349507566659 -1.10963532936873 2222 3 "F2, F7, F10"
"242" "REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS" 0.407516040329973 0.703254274682846 -0.715349507566659 -1.10963532936873 2222 3 "F2, F7, F10"
"243" "REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS" 0.407516040329973 0.703254274682846 -0.715349507566659 -1.10963532936873 2222 3 "F2, F7, F10"
"244" "WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS" 0.407516040329973 0.703254274682846 -0.715349507566659 -1.10963532936873 2222 3 "F2, F7, F10"
"245" "REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS" 0.371814671814672 0.703254274682846 -0.775219383829769 -1.12832474322392 1925 2 "F2"
"246" "REACTOME_GPCR_LIGAND_BINDING" 0.371814671814672 0.703254274682846 -0.775219383829769 -1.12832474322392 1925 2 "F2"
"247" "REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS" 0.371814671814672 0.703254274682846 -0.775219383829769 -1.12832474322392 1925 2 "F2"
"248" "REACTOME_SIGNALING_BY_GPCR" 0.371814671814672 0.703254274682846 -0.775219383829769 -1.12832474322392 1925 2 "F2"
"249" "CAIRO_LIVER_DEVELOPMENT_DN" 0.364464315283987 0.703254274682846 -0.665959282851555 -1.13569716786258 2200 5 "F2, F12, F11, F10"
"250" "BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP" 0.356756756756757 0.703254274682846 -0.783273756557795 -1.14004780927431 1847 2 "C6"
"251" "CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN" 0.356756756756757 0.703254274682846 -0.783273756557795 -1.14004780927431 1847 2 "C6"
"252" "HOSHIDA_LIVER_CANCER_SUBCLASS_S3" 0.352337305224565 0.703254274682846 -0.742297627240102 -1.15143669406307 1921 3 "F2, F11"
"253" "BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP" 0.474186191167323 0.738040338040338 0.689047311199927 1.02596069865016 2286 2 "C2"
"254" "BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"255" "CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"256" "CHENG_IMPRINTED_BY_ESTRADIOL" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"257" "IWANAGA_CARCINOGENESIS_BY_KRAS_UP" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"258" "LIU_COMMON_CANCER_GENES" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"259" "MARTENS_TRETINOIN_RESPONSE_UP" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"260" "MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"261" "RATTENBACHER_BOUND_BY_CELF1" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"262" "SMID_BREAST_CANCER_BASAL_DN" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"263" "STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"264" "STEARMAN_TUMOR_FIELD_EFFECT_UP" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"265" "VANLOO_SP3_TARGETS_DN" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"266" "WANG_CISPLATIN_RESPONSE_AND_XPC_UP" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"267" "XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"268" "ZHU_CMV_24_HR_DN" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"269" "ZHU_CMV_ALL_DN" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"270" "REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"271" "REACTOME_CIRCADIAN_CLOCK" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"272" "WP_CIRCADIAN_RHYTHM_GENES" 0.485267945422187 0.738040338040338 -0.754703386438236 -1.00917924354801 2453 1 "F7"
"273" "ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP" 0.472018983587107 0.738040338040338 -0.762308862380914 -1.01934918394655 2386 1 "F11"
"274" "CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP" 0.472018983587107 0.738040338040338 -0.762308862380914 -1.01934918394655 2386 1 "F11"
"275" "KIM_MYCN_AMPLIFICATION_TARGETS_UP" 0.472018983587107 0.738040338040338 -0.762308862380914 -1.01934918394655 2386 1 "F11"
"276" "KONDO_PROSTATE_CANCER_WITH_H3K27ME3" 0.472018983587107 0.738040338040338 -0.762308862380914 -1.01934918394655 2386 1 "F11"
"277" "PARENT_MTOR_SIGNALING_UP" 0.472018983587107 0.738040338040338 -0.762308862380914 -1.01934918394655 2386 1 "F11"
"278" "REACTOME_DEFECTIVE_F9_ACTIVATION" 0.472018983587107 0.738040338040338 -0.762308862380914 -1.01934918394655 2386 1 "F11"
"279" "BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP" 0.488610038610039 0.738040338040338 -0.71529223378703 -1.04110132286764 2530 2 "C6, F10"
"280" "COATES_MACROPHAGE_M1_VS_M2_DN" 0.488610038610039 0.738040338040338 -0.71529223378703 -1.04110132286764 2530 2 "F7, F10"
"281" "REACTOME_DEFECTIVE_FACTOR_IX_CAUSES_HEMOPHILIA_B" 0.488610038610039 0.738040338040338 -0.71529223378703 -1.04110132286764 2530 2 "F11, F10"
"282" "REACTOME_DEFECTIVE_FACTOR_VIII_CAUSES_HEMOPHILIA_A" 0.488610038610039 0.738040338040338 -0.71529223378703 -1.04110132286764 2530 2 "F2, F10"
"283" "WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS" 0.488610038610039 0.738040338040338 -0.71529223378703 -1.04110132286764 2530 2 "F7, F10"
"284" "MEBARKI_HCC_PROGENITOR_FZD8CRD_DN" 0.479010082493126 0.738040338040338 -0.68152733357985 -1.05717107409933 2612 3 "C6, F10"
"285" "REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION" 0.457360490147375 0.738040338040338 -0.622958499111342 -1.06236555500403 2761 5 "F2, F7, F10"
"286" "REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION" 0.454628780934922 0.738040338040338 -0.693397387800499 -1.07558365618044 2479 3 "F2, F10"
"287" "DODD_NASOPHARYNGEAL_CARCINOMA_DN" 0.51624674196351 0.777068266648907 -0.627943755090031 -1.02206074068588 2970 4 "F3, C6, C9orf72"
"288" "ACEVEDO_LIVER_CANCER_DN" 0.520623281393217 0.780934922089826 -0.65989768203191 -1.02361960692747 2839 3 "F12, F7"
"289" "BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN" 0.546340452000829 0.790111818683247 0.657421590837093 0.97887141228133 2634 2 "C7"
"290" "RODWELL_AGING_KIDNEY_NO_BLOOD_UP" 0.546340452000829 0.790111818683247 0.657421590837093 0.97887141228133 2634 2 "C7"
"291" "SMID_BREAST_CANCER_LUMINAL_B_DN" 0.546340452000829 0.790111818683247 0.657421590837093 0.97887141228133 2634 2 "C7"
"292" "WEST_ADRENOCORTICAL_TUMOR_DN" 0.546340452000829 0.790111818683247 0.657421590837093 0.97887141228133 2634 2 "C7"
"293" "ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"294" "CHYLA_CBFA2T3_TARGETS_UP" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"295" "FOSTER_TOLERANT_MACROPHAGE_UP" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"296" "GUO_HEX_TARGETS_DN" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"297" "IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"298" "KAAB_HEART_ATRIUM_VS_VENTRICLE_UP" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"299" "KUMAR_TARGETS_OF_MLL_AF9_FUSION" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"300" "NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"301" "RAMASWAMY_METASTASIS_DN" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"302" "WANG_TARGETS_OF_MLL_CBP_FUSION_UP" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"303" "WINNEPENNINCKX_MELANOMA_METASTASIS_DN" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"304" "WONG_ENDMETRIUM_CANCER_DN" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"305" "YOSHIMURA_MAPK8_TARGETS_UP" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"306" "ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"307" "ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR" 0.562586513743326 0.790111818683247 -0.715234969177808 -0.956402605479784 2844 1 "F10"
"308" "RASHI_RESPONSE_TO_IONIZING_RADIATION_5" 0.563320463320463 0.790111818683247 -0.673690348577676 -0.980550158351379 2917 2 "F7"
"309" "WP_COMPLEMENT_AND_COAGULATION_CASCADES" 0.599800730654268 0.833163715892745 0.377614615428542 0.889140226042563 1805 10 "C2"
"310" "WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES" 0.599800730654268 0.833163715892745 0.377614615428542 0.889140226042563 1805 10 "C2"
"311" "CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN" 0.596911196911197 0.833163715892745 -0.654944586895218 -0.953265873182445 3091 2 "F3"
"312" "KEGG_COMPLEMENT_AND_COAGULATION_CASCADES" 0.613494809688581 0.849454351876497 0.362628702361986 0.879156927427545 1772 11 "C2"
"313" "JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN" 0.759900476881609 0.884419523853295 0.554959618873483 0.826310108242866 3664 2 "C7"
"314" "BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"315" "BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"316" "BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"317" "BOYLAN_MULTIPLE_MYELOMA_C_D_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"318" "BOYLAN_MULTIPLE_MYELOMA_PCA1_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"319" "BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"320" "BURTON_ADIPOGENESIS_5" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"321" "CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"322" "CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"323" "CHICAS_RB1_TARGETS_SENESCENT" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"324" "DAUER_STAT3_TARGETS_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"325" "DEMAGALHAES_AGING_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"326" "GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"327" "GERY_CEBP_TARGETS" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"328" "GOLDRATH_ANTIGEN_RESPONSE" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"329" "GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"330" "GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"331" "GROSS_HIF1A_TARGETS_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"332" "GROSS_HYPOXIA_VIA_ELK3_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"333" "HAN_JNK_SINGALING_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"334" "HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"335" "HUMMERICH_SKIN_CANCER_PROGRESSION_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"336" "IGLESIAS_E2F_TARGETS_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"337" "INGRAM_SHH_TARGETS_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"338" "IVANOVA_HEMATOPOIESIS_MATURE_CELL" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"339" "JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"340" "JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"341" "JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"342" "JOHNSTONE_PARVB_TARGETS_3_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"343" "KANG_IMMORTALIZED_BY_TERT_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"344" "KASLER_HDAC7_TARGETS_1_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"345" "KIM_GLIS2_TARGETS_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"346" "KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"347" "LENAOUR_DENDRITIC_CELL_MATURATION_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"348" "LIANG_SILENCED_BY_METHYLATION_2" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"349" "LIANG_SILENCED_BY_METHYLATION_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"350" "LIM_MAMMARY_LUMINAL_PROGENITOR_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"351" "LIU_VAV3_PROSTATE_CARCINOGENESIS_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"352" "LI_INDUCED_T_TO_NATURAL_KILLER_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"353" "MARTIN_NFKB_TARGETS_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"354" "MARTIN_VIRAL_GPCR_SIGNALING_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"355" "MCLACHLAN_DENTAL_CARIES_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"356" "MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"357" "NAKAMURA_METASTASIS_MODEL_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"358" "NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"359" "NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"360" "ONDER_CDH1_SIGNALING_VIA_CTNNB1" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"361" "RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"362" "RUTELLA_RESPONSE_TO_HGF_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"363" "RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"364" "SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"365" "SAUL_SEN_MAYO" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"366" "SCHOEN_NFKB_SIGNALING" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"367" "SENESE_HDAC1_AND_HDAC2_TARGETS_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"368" "SENESE_HDAC1_TARGETS_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"369" "SHEN_SMARCA2_TARGETS_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"370" "SWEET_LUNG_CANCER_KRAS_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"371" "TSUNODA_CISPLATIN_RESISTANCE_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"372" "WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"373" "WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"374" "WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"375" "WOOD_EBV_EBNA1_TARGETS_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"376" "ZHENG_IL22_SIGNALING_UP" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"377" "KEGG_LEISHMANIA_INFECTION" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"378" "PID_ERA_GENOMIC_PATHWAY" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"379" "PID_ERB_GENOMIC_PATHWAY" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"380" "REACTOME_ADAPTIVE_IMMUNE_SYSTEM" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"381" "REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"382" "REACTOME_G_ALPHA_I_SIGNALLING_EVENTS" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"383" "REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"384" "REACTOME_INFECTIOUS_DISEASE" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"385" "REACTOME_LEISHMANIA_INFECTION" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"386" "REACTOME_NEUTROPHIL_DEGRANULATION" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"387" "REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"388" "WP_16P112_DISTAL_DELETION_SYNDROME" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"389" "WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"390" "WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"391" "WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"392" "WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA" 0.810717896865521 0.884419523853295 0.596029140981507 0.79164514226601 4008 1 "C3"
"393" "SMID_BREAST_CANCER_NORMAL_LIKE_UP" 0.802287222344403 0.884419523853295 0.449144586087908 0.740571557542086 3647 3 "C7"
"394" "ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN" 0.781484876260312 0.884419523853295 -0.476366842184545 -0.738930372127966 4262 3 "F12"
"395" "KIM_LIVER_CANCER_POOR_SURVIVAL_DN" 0.684555984555985 0.884419523853295 -0.604855942346266 -0.880362307845977 3545 2 "F10"
"396" "BOQUEST_STEM_CELL_UP" 0.64100016559033 0.884419523853295 -0.528085797425918 -0.900573893882872 3870 5 "F3, C6"
"397" "SHEPARD_BMYB_MORPHOLINO_DN" 0.856949806949807 0.891571644116263 -0.461598488058343 -0.671852389626713 4438 2 "F7"
"398" "ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"399" "BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"400" "BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"401" "FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"402" "FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"403" "GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"404" "HAHTOLA_SEZARY_SYNDROM_UP" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"405" "JAATINEN_HEMATOPOIETIC_STEM_CELL_DN" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"406" "LEIN_CHOROID_PLEXUS_MARKERS" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"407" "MACAEVA_PBMC_RESPONSE_TO_IR" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"408" "ROY_WOUND_BLOOD_VESSEL_DN" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"409" "SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"410" "TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"411" "TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"412" "REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"413" "REACTOME_CARGO_CONCENTRATION_IN_THE_ER" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"414" "REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"415" "REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"416" "REACTOME_MEMBRANE_TRAFFICKING" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"417" "REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"418" "REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"419" "REACTOME_VESICLE_MEDIATED_TRANSPORT" 0.864741941862764 0.891571644116263 -0.567448562965335 -0.758784605735472 4372 1 "F5"
"420" "VECCHI_GASTRIC_CANCER_EARLY_DN" 0.869477543538039 0.894319759067697 -0.40944842888661 -0.635127916411916 4742 3 "C6, F11"
"421" "CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3" 0.917478747667427 0.941450876466338 0.432586068855084 0.644101353005812 4424 2 "C3, F5"
"422" "PID_INTEGRIN2_PATHWAY" 0.925482625482625 0.947413493385057 -0.40400320256205 -0.588022976851369 4793 2 "F10, C3"
"423" "BORCZUK_MALIGNANT_MESOTHELIOMA_DN" 0.957722007722008 0.966672680691372 -0.36468135057993 -0.530790379903618 4960 2 "C6"
"424" "DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP" 0.957722007722008 0.966672680691372 -0.36468135057993 -0.530790379903618 4960 2 "C6"
"425" "KEGG_PRION_DISEASES" 0.957722007722008 0.966672680691372 -0.36468135057993 -0.530790379903618 4960 2 "C6"
"426" "KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION" 0.957722007722008 0.966672680691372 -0.36468135057993 -0.530790379903618 4960 2 "C6"
"427" "KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION" 0.957722007722008 0.966672680691372 -0.36468135057993 -0.530790379903618 4960 2 "C6"
"428" "REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT" 0.957722007722008 0.966672680691372 -0.36468135057993 -0.530790379903618 4960 2 "C6"
"429" "BIOCARTA_ALTERNATIVE_PATHWAY" 0.972318973418882 0.972318973418882 -0.306345480212423 -0.475196759402896 5303 3 "C6"
"430" "BIOCARTA_LAIR_PATHWAY" 0.972318973418882 0.972318973418882 -0.306345480212423 -0.475196759402896 5303 3 "C6"
"431" "WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE" 0.972318973418882 0.972318973418882 -0.306345480212423 -0.475196759402896 5303 3 "C6"
"432" "WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY" 0.972318973418882 0.972318973418882 -0.306345480212423 -0.475196759402896 5303 3 "C6"
